Floatz logo

PITAVASTATIN

Hypercholesterolemia

JW PharmaceuticalSmall moleculePhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Hypercholesterolemia cohort.

Asset / SponsorPhaseRating
Ezetimibe
Punjab Institute of Cardology
Phase 4BBB
Lipitor
Punjab Institute of Cardology
Phase 4BBB
SIMVASTATIN
paresh Dandona
Phase 4BBB
PRAVASTATIN
Yokohama City University Medical Center
Phase 4BB
Rosuvastatin
Sanofi
Phase 4BB

View all 36 →

Same molecule, other indications

PITAVASTATIN is also rated in:

coronary artery disorderDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →
inflammatory diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →